

Track Respiratory Pathogen Activity at Your Local Level
Wastewater data help track the activity of respiratory pathogens. These data help detect the presence and quantities of pathogens within the larger community.1,2
On this page:
Up-to-date pathogen activity
Click on a disease state tab and then on state or county to see your regional or local circulation of that pathogen.
Map shows interpolated wastewater concentrations for all US counties. Direct wastewater data are not available for every county. Values are based on actual samples from a subset of wastewater treatment facilities and modeled estimates for counties without direct measurements. For SARS-CoV-2, the color scale on the map is designed to use data exclusively from 2022 and later, with the highest activity levels being correlated with peak activity during these years. Wastewater samples contain a mix of DNA and RNA from bacteria, viruses, animals, humans, and other living things.2
All wastewater data are presented as is and have not been verified by Sanofi. Wastewater activity should not be interpreted in isolation as the absence or presence of disease risk or to assess individual patient risk.
Tracking pathogen circulation can alert you to when patients may be at elevated risk of exposure2
Wastewater samples collected weekly are analyzed for the presence of biomarkers of infection, most commonly pathogen DNA or RNA. The genetic material can be shed when infected persons wash their hands, brush their teeth, take a shower, or use the bathroom.
As Biobot Analytics samples are processed, data and models are updated on a rolling basis multiple times per week.
Biobot collects wastewater samples from communities across the US, representing ~23% of the US population. Interpolation-generated, county-level enhanced datasets are updated weekly, representing 100% of US counties.
Biobot's model estimates the concentration of pathogens in wastewater across the US through an interpolation approach that makes use of population density and sampling location data, among other information. The model uses a statistical machine learning model and does not use generative AI.
What the data can tell us1
- Estimated circulation of these respiratory pathogens in your local environment
- An early warning that infectious diseases may be spreading in a community
- An efficient approach that can detect infection in a community, regardless of whether people have symptoms or seek medical care
- Data for communities where patients aren't always able to get tested for infectious diseases
These activity levels may correlate with clinical burden and may provide a visual aid to guide prevention steps.2

Wastewater detection levels may remain elevated even as community circulation wanes2
At times, the map may report elevated levels of circulating pathogens even as community circulation wanes. Two potential reasons for this are (in an example for RSV):
- Prolonged shedding: Infected people may continue to shed the virus for days after symptoms resolve
- Subclinical or mild infections: Some individuals, especially older children and adults, may have mild or asymptomatic infections that don’t require hospitalization or testing
Frequently consulting the wastewater map can keep you informed of circulating viral activity trends, even at times believed to have reduced circulation.
Additional details about the data
Samples are collected at wastewater treatment plants (typically 24-hour composite samples that are kept chilled) and shipped to Biobot's lab, where genetic material is extracted and quantified using PCR with pathogen-specific targets. Results are normalized against a fecal biomarker (PMMoV) to account for dilution and population changes over time. Before release, the results pass through Biobot's quality control checks and data science team for trend review.2
While some testing locations may overlap, CDC and Biobot now operate separate, independent networks of testing sites. The CDC aggregates results from multiple laboratories that use different PCR methods, which tends to smooth out regional differences. In contrast, Biobot analyzes all samples at a single, centralized lab.2
Biobot’s network includes more urban than rural sites, and Biobot uses proprietary methods to analyze the data.2
Please visit the Biobot website for more information on methodology.
Biobot is a third-party corporation which is not controlled by Sanofi.
Biobot's activity tiers for COVID-19 are based on analysis of wastewater and hospitalization data from after the pandemic public health emergency ended, and reflects the range of activity that has been observed in these data sources over the past two years from July 2024 through July 2026.2
Biobot's RSV activity tiers are linked to hospitalization rates as measured by CDC's RSV-NET, so a given wastewater activity tier corresponds to a range of hospitalization rates.2
What can I do as a clinician?
You can use this tool with other data sources to stay informed about respiratory pathogen activity
Checking wastewater maps can help ensure that patients are getting immunized at recommended times, before respiratory pathogen signals become high.
During periods of high circulation, it can also help ensure early identification of signs and symptoms of respiratory disease.
To order immunizations or visit disease-state websites, go to:
Which pathogens are captured in these wastewater data?2,3
Two respiratory pathogens that circulate in wastewater and are monitored with Biobot data are:
- RSV
- SARS-CoV-2, the causative agent of COVID-19
Sanofi & Biobot Analytics partnership
Our commitment to protecting health
At Sanofi, we’re dedicated to helping protect people of all ages from respiratory illnesses, including RSV and COVID-19. Through our partnership with Biobot Analytics, we regularly provide healthcare providers with timely, updated respiratory pathogen activity data to support informed decisions and help protect communities.

AAP, American Academy of Pediatrics; AI, artificial intelligence; CDC, Centers for Disease Control and Prevention; PCR, polymerase chain reaction; PMMoV, pepper mild mottle virus; RSV, respiratory syncytial virus; RSV-NET, Respiratory Syncytial Virus Hospitalization Surveillance Network; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
References: 1. About wastewater data. Centers for Disease Control and Prevention. Updated August 14, 2026. Accessed September 17, 2026. https://www.cdc.gov/nwss/about-data.html 2. Data on File. Sanofi. 3. About COVID-19. Centers for Disease Control and Prevention. Updated June 13, 2024. Accessed September 17, 2026. https://www.cdc.gov/COVID/about/index.html 4. About RSV. Centers for Disease Control and Prevention. Updated December 30, 2025. Accessed September 17, 2026. https://www.cdc.gov/rsv/about/index.html 5. Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, et al. Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018;217(9):1356-1364. 6. Abu-Raya B, Viñeta Paramo M, Reicherz F, et al. Why has the epidemiology of RSV changed during the COVID-19 pandemic? EClinicalMedicine. 2023;61:102089. 7. Symptoms and care of RSV. Centers for Disease Control and Prevention. Updated February 20, 2026. Accessed September 17, 2026. https://www.cdc.gov/rsv/symptoms/index.html 8. Symptoms of COVID-19. Centers for Disease Control and Prevention. Updated March 10, 2025. Accessed September 17, 2026. https://www.cdc.gov/covid/signs-symptoms/index.html 9. How to tell the difference between flu, RSV, COVID-19, and the common cold. National Foundation for Infectious Diseases. Accessed October 28, 2026. https://www.nfid.org/resource/how-to-tell-the-difference-between-flu-rsv-covid-19-and-the-common-cold/ 10. Recommended child and adolescent immunization schedule for ages 18 years or younger. American Academy of Pediatrics. Updated September 2, 2026. Accessed September 17, 2026. https://downloads.aap.org/AAP/PDF/AAP-Immunization-Schedule.pdf


